Scientists at Emory Vaccine Center, in collaboration with investigators from Thailand, have found that people infected with dengue virus develop antibodies that cross-react with Zika virus.
Some of these antibodies have the potential to neutralize Zika virus - possibly providing immune protection. At the same time, in laboratory experiments, antibodies against dengue could enhance Zika virus infection of human cells.
The results are scheduled for publication on Monday, June 27 in PNAS.